Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 8/20 | 0.84 |
| ▸ | HTT | P42858 | 7/20 | 0.84 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.84 |
| ▸ | NPSR1 | Q6W5P4 | 6/20 | 0.84 |
| ▸ | MEN1 | O00255 | 6/20 | 0.84 |
| ▸ | NPC1 | O15118 | 5/20 | 0.84 |
| ▸ | L3MBTL1 | Q9Y468 | 5/20 | 0.84 |
| ▸ | POLB | P06746 | 5/20 | 0.84 |
| ▸ | MAPT | P10636 | 5/20 | 0.84 |
| ▸ | NSD2 | O96028 | 4/20 | 0.84 |
| ▸ | PKM | P14618 | 4/20 | 0.84 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.84 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.84 |
| ▸ | THRB | P10828 | 3/20 | 0.84 |
| ▸ | LMNA | P02545 | 3/20 | 0.84 |
| ▸ | RAD52 | P43351 | 2/20 | 0.84 |
| ▸ | PPARG | P37231 | 2/20 | 0.84 |
| ▸ | NCOA2 | Q15596 | 2/20 | 0.84 |
| ▸ | NCOA1 | Q15788 | 2/20 | 0.84 |
| ▸ | RECQL | P46063 | 2/20 | 0.84 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5701148 | 1.00 | RAB9A (0.84) | RAB9AHTTKMT2ANPSR1MEN1 | |
| Perchlorate SCHEMBL1405333 | 0.95 | RAB9A (0.77) | RAB9AHTTKMT2ANPSR1MEN1 | |
| Perchlorate SCHEMBL7130210 | 0.95 | RAB9A (0.77) | RAB9AHTTKMT2ANPSR1MEN1 | |
| SCHEMBL13428296 | 0.92 | MEN1 (0.97) | RAB9AHTTKMT2ANPSR1MEN1 | |
| SCHEMBL10036010 | 0.92 | MEN1 (0.97) | RAB9AHTTKMT2ANPSR1MEN1 | |
| Iodide SCHEMBL11803644 | 0.91 | MEN1 (1.00) | RAB9AHTTKMT2ANPSR1MEN1 | |
| Perchlorate SCHEMBL7696414 | 0.89 | RAB9A (0.67) | RAB9AHTTKMT2ANPSR1MEN1 | |
| SCHEMBL6906359 | 0.83 | HTT (0.66) | RAB9AHTTKMT2ANPSR1MEN1 | |
| SCHEMBL5510788 | 0.83 | HTT (0.66) | RAB9AHTTKMT2ANPSR1MEN1 | |
| SCHEMBL14984123 | 0.81 | MEN1 (0.77) | RAB9AHTTKMT2ANPSR1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9242015-B2 | Development and screening of contrast agents for in vivo imaging of Parkinson's disease | THE GENERAL HOSPITAL CORPORATION (US) | 2016-01-26 | — | — | US | claimed |
| US-20130259805-A1 | DEVELOPMENT AND SCREENING OF CONTRAST AGENTS FOR IN VIVO IMAGING OF PARKINSON'S DISEASE | THE GENERAL HOSPITAL CORPORATION (US) | 2013-10-03 | — | — | US | claimed |
| WO-2012065045-A2 | DEVELOPMENT AND SCREENING OF CONTRAST AGENTS FOR IN VIVO IMAGINING OF PARKINSON'S DISEASE | THE GENERAL HOSPITAL CORPORATION (US) | 2012-05-18 | — | — | WO | claimed |
| US-9242015-B2 | Development and screening of contrast agents for in vivo imaging of Parkinson's disease | THE GENERAL HOSPITAL CORPORATION (US) | 2016-01-26 | — | — | US | disclosed |
| US-9222934-B2 | Reagent and reagent kit for analysis of immature leukocyte | SYSMEX CORPORATION (JP) | 2015-12-29 | — | — | US | disclosed |
| US-8906354-B2 | Loaded latex optical molecular imaging probes containing lipophilic large stokes shift dyes | BRUKER BIOSPIN CORPORATION (US) | 2014-12-09 | — | — | US | disclosed |
| US-8859200-B2 | Reagent and reagent kit for analysis of immature leukocyte | SYSMEX CORPORATION (JP) | 2014-10-14 | — | — | US | disclosed |
| US-8841134-B2 | Fluorescence resonance energy transfer detection with nanoparticles for in vitro and in vivo applications | BRUKER BIOSPIN CORPORATION (US) | 2014-09-23 | — | — | US | disclosed |
| US-20130259805-A1 | DEVELOPMENT AND SCREENING OF CONTRAST AGENTS FOR IN VIVO IMAGING OF PARKINSON'S DISEASE | THE GENERAL HOSPITAL CORPORATION (US) | 2013-10-03 | — | — | US | disclosed |
| EP-2166354-B1 | REAGENT AND REAGENT KIT FOR ANALYSIS OF PRIMITIVE LEUKOCYTE | SYSMEX CORP (JP) | 2012-11-07 | — | — | EP | disclosed |
| WO-2012065045-A2 | DEVELOPMENT AND SCREENING OF CONTRAST AGENTS FOR IN VIVO IMAGINING OF PARKINSON'S DISEASE | THE GENERAL HOSPITAL CORPORATION (US) | 2012-05-18 | — | — | WO | disclosed |
| US-20120058050-A1 | LOADED LATEX OPTICAL MOLECULAR IMAGING PROBES CONTAINING LIPOPHILIC LARGE STOKES SHIFT DYES | BRUKER BIOSPIN CORPORATION | 2012-03-08 | — | — | US | disclosed |
| US-20100034748-A1 | Molecular imaging probes based on loaded reactive nano-scale latex | QUANTUM MEDICAL HOLDINGS, LLC | 2010-02-11 | — | — | US | disclosed |
| US-20090061532-A1 | FLUORESCENCE RESONANCE ENERGY TRANSFER DETECTION WITH NANOPARTICLES FOR IN VITRO AND IN VIVO APPLICATIONS | CARESTREAM HEALTH, INC. | 2009-03-05 | — | — | US | disclosed |
| US-20080181965-A1 | Loaded latex optical molecular imaging probes | QUANTUM MEDICAL HOLDINGS, LLC | 2008-07-31 | — | — | US | disclosed |
| US-7151623-B2 | Holographic data-storage medium | TESA SCRIBOS GMBH (DE) | 2006-12-19 | — | — | US | disclosed |
| EP-1395985-B1 | HOLOGRAPHIC DATA-STORAGE MEDIUM | TESA SCRIBOS GMBH (DE) | 2006-09-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080181965-A1 | Loaded latex optical molecular imaging probes | MLX, LOXL1, EPX | RAB9A 4669/4885HTT 3673/4885KMT2A 2878/4885 |
| US-20100034748-A1 | Molecular imaging probes based on loaded reactive nano-scale latex | CLTA, COPE, CD68 | RAB9A 4122/4885HTT 129/4885KMT2A 2753/4885 |
| US-20120058050-A1 | LOADED LATEX OPTICAL MOLECULAR IMAGING PROBES CONTAINING LIPOPHILIC LARGE STOKES SHIFT DYES | LASP1, LSS, SELL | RAB9A 1834/4885HTT 2631/4885KMT2A 3321/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.